MESA LABORATORIES INC /CO/ Quarterly Deferred Income Tax Expense (Benefit) in USD for Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Mesa Laboratories Inc /Co/ annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate for Q2 2022.
  • Mesa Laboratories Inc /Co/ Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was -$908K.
  • Mesa Laboratories Inc /Co/ annual Deferred Income Tax Expense (Benefit) for 2023 was -$28.4M, a 707% decline from 2022.
  • Mesa Laboratories Inc /Co/ annual Deferred Income Tax Expense (Benefit) for 2022 was -$3.52M, a 2850% decline from 2021.
  • Mesa Laboratories Inc /Co/ annual Deferred Income Tax Expense (Benefit) for 2021 was $128K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 -$908K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.